$VLTO

Honeycutt Jennifer sold $720K of VLTO

Honeycutt Jennifer (President and CEO) sold 7,097 shares of Veralto Corp (VLTO) at $101.52 ($0.72M total) on 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Honeycutt Jennifer
Published Jul 31, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VLTO
Neutral
high confidence
Mentioned
$VLTO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VLTONeutralLow
01

Why it matters

The disclosed fact is an open-market sale of 7,097 shares at $101.52, totaling about $720.5K, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly factor in insider-selling sentiment, but the 10b5-1 designation makes it more consistent with routine liquidity than a new negative thesis.

03

What to watch

The article provides no context on total planned sales, remaining tranche size, or whether other insiders are selling, limiting inference from this single transaction.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-31 after-hours; sale dated 2026-07-29

Background

The article is an SEC Form 4 insider transaction disclosure for Veralto Corp (VLTO) by its President and CEO.

Company-level read

Ticker impact

$VLTONeutralHigh confidence
Context

Veralto CEO Jennifer Honeycutt filed a Form 4 selling 7,097 shares at $101.52 on 2026-07-29 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment around insider selling.

Evidence & confidence

The filing specifies an open-market sale and a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

Minimal; insider-sale mechanics do not indicate sector-wide changes.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with valuation or liquidity needs, so traders may watch for follow-on selling patterns.

Key entities

  • Veralto Corp

    Subject of the Form 4 insider transaction disclosure.

  • Jennifer Honeycutt

    President and CEO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Veralto’s Deal Machine Is Picking Up Speed

Veralto has spent $2.2B on M&A and buybacks since its 2023 spinoff, according to RBC. The acquisition of Cleanwater1 for $465M aims to expand its water disinfection platform, driving recurring revenue. RBC expects cost savings to boost operating leverage from 2027, potentially increasing cash for further deals and buybacks.

HighAI 9/10

Veralto to acquire Cleanwater1

Veralto agreed to acquire Cleanwater1, a provider of water treatment technologies, for a net price of $452 million. The deal is expected to close in Q4 2026 and expand Veralto's portfolio into high-growth areas, with synergies from its Trojan Technologies unit.

HighAI 9/10

Veralto to acquire Cleanwater1 in $465 million deal

Veralto to acquire Cleanwater1 for $465M. Cleanwater1 specializes in water treatment tech, with $135M sales in the last year. Veralto expects the deal to be neutral to modestly accretive to earnings in 2027. Cleanwater1's tech complements Veralto's portfolio and expands its market reach.

$VLTOMedAI 8/10

Veralto Signs Agreement To Acquire Cleanwater1

Veralto (VLTO) agreed to acquire Cleanwater1 for $465M, with a net price of $452M after tax benefits. The deal, expected to close in Q4 2026, adds ~25,000 units to Veralto's portfolio, expanding its water treatment offerings. Cleanwater1 had $135M in LTM sales, growing at a low double-digit CAGR since 2023. Veralto expects the acquisition to be neutral to modestly accretive to EPS in 2027.